Inventor
RIZZI ANDREA
IT21 patents
⚠️ This page may combine multiple inventors who share the name “RIZZI ANDREA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHIESI FARM SPA
9 patentsUS10004728B2Jun 26, 2018
Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity
CHIESI FARM SPA2 citations72
US9579314B2Feb 28, 2017
Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity
CHIESI FARM SPA2 citations72
US9662323B2May 30, 2017
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
CHIESI FARM SPA2 citations62
US10280193B2May 7, 2019
Isoxazolidine derivatives
CHIESI FARM SPA0 citations51
US9845337B2Dec 19, 2017
Isoxazolidine derivatives
CHIESI FARM SPA0 citations51
US12454530B2Oct 28, 2025
Amido cyclohexane acid derivatives as LPA receptor inhibitors
CHIESI FARM SPA0 citations47
US10196386B2Feb 5, 2019
Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity
CHIESI FARM SPA0 citations40
US10087176B2Oct 2, 2018
3,5-dichloro,4-(3,4-(cyclo-)alkoxyphenyl)--2-carbonyloxy)ethyl)pyridine derivatives as PDE-4 inhibitors
CHIESI FARM SPA0 citations40
US9932338B2Apr 3, 2018
Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity
CHIESI FARM SPA0 citations40
CHIESI FARMA SPA
6 patentsUS8022250B2Sep 20, 2011
1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
CHIESI FARMA SPA10 citations81
US7820698B2Oct 26, 2010
Phosphodiesterase-4 inhibitors belonging to the tertiary amine class
CHIESI FARMA SPA16 citations81
US7662995B2Feb 16, 2010
1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
CHIESI FARMA SPA12 citations81
US9199980B2Dec 1, 2015
Compounds
CHIESI FARMA SPA5 citations72
US7838534B2Nov 23, 2010
Quinuclidine derivatives as M3 antagonists
CHIESI FARMA SPA2 citations57
US7531692B2May 12, 2009
Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases
CHIESI FARMA SPA1 citations49